Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease
The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Creatine is of paramount importance for maintaining and managing cellular ATP stores in both physiological and pathological states. Besides these "ergogenic" actions, it has a number of additional "pleiotropic" effects, e.g., antioxidant activity, neurotransmitter-like behavior, prevention of opening of mitochondrial permeability pore and others. Creatine supplementation has been proposed for a number of conditions, including neurodegenerative diseases. However, it is likely that creatine's largest therapeutic potential is in those diseases caused by energy shortage or by increased energy demand; for example, ischemic stroke and other cerebrovascular diseases. Surprisingly, despite a large preclinical body of evidence, little or no clinical research has been carried out in these fields. However, recent work showed that high-dose creatine supplementation causes an 8-9 % increase in cerebral creatine content, and that this is capable of improving, in humans, neuropsychological performances that are hampered by hypoxia. In addition, animal work suggests that creatine supplementation may be protective in stroke by increasing not only the neuronal but also the endothelial creatine content. Creatine should be administered before brain ischemia occurs, and thus should be given for prevention purposes to patients at high risk of stroke. In myocardial ischemia, phosphocreatine has been used clinically with positive results, e.g., showing prevention of arrhythmia and improvement in car…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the CK/PCr system thereby serves as an important regulator of metabolism which may help explain the ergogenic and potential therapeutic health benefits of creatine supplementation”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [33]
In the citing paper
“This coupling also reduces the formation of reactive oxygen species (ROS) and can therefore act as a direct and/or indirect antioxidant”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [33]
In the citing paper
“These findings provide strong evidence that creatine supplementation may limit damage from concussions, TBI, and/or SCI”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [33]
In the citing paper
“In a recent review, Balestrino and colleagues [33] concluded that phosphocreatine administration, primarily as an addition to cardioplegic solutions, has been used to treat myocardial ischemia and prevent ischemia-induced arrhythmia and improve cardiac function with some success.”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [33]
In the citing paper
“Creatine and phosphocreatine play an important role in maintaining myocardial bioenergetics during ischemic events [33].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [33]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development
(1999) · Stroke · doi:10.1161/01.str.30.12.2752 · Cited by 1,251
The creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Lauritzen, M., Dreier, J. P., Fabricius, M., Hartings, J. A., Graf, R., & Strong, A. J. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.191 · Cited by 782
Neubauer, S., Horn, M., Cramer, M., Harre, K., Newell, J. B., Peters, W., Pabst, T., Ertl, G., Hahn, D., Ingwall, J. S., et al. (1997) · Circulation · doi:10.1161/01.cir.96.7.2190 · Cited by 745
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/6568 · Cited by 682
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity
Matthews, R. T., Ferrante, R. J., Klivenyi, P., Yang, L., Klein, A. M., Mueller, G., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7049 · Cited by 373
Functions and effects of creatine in the central nervous system
Andres, R. H., Ducray, A. D., Schlattner, U., Wallimann, T., & Widmer, H. R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.02.035 · Cited by 368
Increase of total creatine in human brain after oral supplementation of creatine-monohydrate
Dechent, P., Pouwels, P. J. W., Wilken, B., Hanefeld, F., & Frahm, J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r698 · Cited by 221
Research works printed but not linked: 6
- Coraggio F, Spina M, Scarpato P (1987) Analysis of creatine phosphate on the evolution of ischemic lesion in acute myocardial infarction. Farmaci Terapia 4:91–93
- Ingwall JS (1993) Is cardiac failure a consequence of decreased energy reserve? Circulation 87:58–62
- Iosseliani DG, Koledinsky AG, Kuchkina NV (2004) Does intracoronary injection of phosphocreatine prevent myocardial reperfusion injury following angioplasty of infarct-related artery in acute-stage of myocardial infarction? J Intervent Cardiol 6:10–14
- Iosseliani DG, Koledinsky AG, Kuchkina NV (2006) The possibility to limit reperfusion injury of cardiomyocytes using intracoronary cytoprotectors during endovascular reperfusion of the infarct-related artery. J Intervent Cardiol 11:10–16
- Raisaro A, Bargiggia CS, Bertucci C (1989) Clinical evaluation of phosphocreatine effect during acute myocardial infarction: A multicenter study: 139147. Proceedings of the International Meeting “Cardioprotection with phosphocreatine in cardiology and cardiac surgery” IRCCS, Policlinico S. Matteo, Università degli studi, Pavia
- Skřivánek O, Kalvach Pavel, Benetin Ján, Brzák M, Kukumberg I, Strnad P, Strnadová V, Traubner Pavol, Turčány P, Vávra P (1995) Waberžinek, Gerhard. Kreatinfosfát v léčbě akutních ischemických iktů. Prakticky Lekar 75:7–8
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“In a recent review, Balestrino and colleagues [33] concluded that phosphocrea-”
BackgroundWu, G. (2020) · Amino Acids · doi:10.1007/s00726-020-02823-6 · Cited by 475
Antonio, J., Candow, D. G., Forbes, S. C., Gualano, B., Jagim, A. R., Kreider, R. B., Rawson, E. S., Smith-Ryan, A. E., VanDusseldorp, T. A., Willoughby, D. S., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-021-00412-w · Cited by 345
“Finally, there is evidence from animal models that creatine supplementation is neuroprotective [147–149] and can reduce the severity of spinal cord injury [150, 151], cerebral ischemia [152–155], and concussion/traumatic brain injury [2, 7, 12, 22, 32, 33, 156].”
BackgroundCreatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
“Creatine supplementation has been reported to increase brain PCr content by 5–15% and thereby enhance brain bioenergetics [21,53,69,131,171].”
BackgroundInfluentialBalestrino, M., & Adriano, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21590 · Cited by 90
“This auspice originates from the strong rationale for its effectiveness and from the impressive amount of preclinical data showing the effectiveness of creatine pretreatment in reducing ischemic damage.(16,17) Importantly, clinical experience in the past couple of decades has largely reassured on the safety of creatine”
BackgroundSelf-citation
Metadata
- Authors
- Balestrino, M., Sarocchi, M., Adriano, E., & Spallarossa, P.
- Affiliations
- University of Genoa (IT)
- Corresponding author
- Balestrino, Maurizio
- Venue
- Amino Acids
- Published
- 2016-01-21
- Volume
- 48
- Issue
- 8
- Pages
- 1955-1967
- ISSN
- 0939-4451 (ISSN-L)
- 1438-2199
- OpenAlex
- W2275117202
- Cited by
- 60
- References
- 108
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 4 · 2023: 7 · 2022: 7 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 2 · 2016: 4
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Amino Acids (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Funders
- Telethon Italy (GEP 13019)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Keywords
- creatine supplementation, phosphocreatine, cerebrovascular disease, ischemic stroke, ischemic heart disease, myocardial ischemia, hypoxia, antioxidant activity, cardioplegic solution, arrhythmia prevention, reperfusion
- MeSH terms
- Animals, Hypoxia, Brain, Humans, Phosphocreatine, Myocardial Ischemia, Dietary Supplements, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. https://app.cochat.ai/papers/10.1007/s00726-016-2173-8
- The paper
- Balestrino, M., Sarocchi, M., Adriano, E., & Spallarossa, P. (2016). Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease. Amino Acids. https://doi.org/10.1007/s00726-016-2173-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.